Source: International Congress 2017 – How can microbiology and translational research help physicians?
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Basile (Palermo, Italy). Positive predictive value of breathprint analysis for clinical remission of acute LRTI and for differentiation between AE-COPD and CAP. 3324

Member's Comments

No comment yet.

Related content which might interest you: Prognostic predictors of survival in patients with COPD hospitalized for an acute exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005 Is RSV positive testing predictive of a more severe course of disease in patients with acute bronchiolitis admitted to hospital? Source: Eur Respir J 2005; 26: Suppl. 49, 627s Year: 2005 A new early predictive index for hospitalisation in acute exacerbations of asthma Source: Annual Congress 2008 - Mechanical ventilation and airway management Year: 2008 Mortality predictive variables in the short-term before a COPD exacerbation Source: Eur Respir J 2006; 28: Suppl. 50, 177s Year: 2006 Predictive value of multiorgan imaging biomarkers for predicting exacerbations in COPD patients Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Clinical diagnosis of current asthma: predictive value of respiratory symptoms in the SAPALDIA study Source: Eur Respir J 2001; 17: 214-219 Year: 2001 The significance of the adherence to the discharge criteria in patients with acute exacerbation of COPD on early readmission Source: International Congress 2017 – COPD management Year: 2017 Associations of COPD severity and severity of exacerbation with sputum microbiologic profile and long-term survival Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 A comparative validation of early predictive indices of hospitalisation in acute severe asthma Source: Annual Congress 2008 - Acute lung injury and weaning Year: 2008 Clinical and exacerbation characteristics may predict treatment response in acute exacerbations of COPD Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Prognostic evaluation of COPD patients with pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 257s Year: 2005 The validity of the EQ5D5L in patients hospitalized an acute exacerbation of COPD Source: International Congress 2017 – Latest insights into chronic care Year: 2017 The prognostic value of procalcitonin in patients with hypoxemic COVID 19 pneumonia. Source: Virtual Congress 2021 – COVID - 19 biomarkers Year: 2021 Sit-to-stand ability in patients hospitalised for acute exacerbation of COPD: Clinical characteristics and short-term outcomes Source: International Congress 2015 – New insights into exercise and muscle performance Year: 2015 preditive factors of severe outcome in patients with covid-19 pneumonia Source: Virtual Congress 2021 – COVID - 19 risk predictions Year: 2021 Sputum bacteriology in acute COPD exacerbations: correlation with FEV1 deterioration Source: Eur Respir J 2001; 18: Suppl. 33, 189s Year: 2001 Usefulness of severity predictive scores in COPD exacerbations in hospitalized patients Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Temporal profile and clinical utility of inflammatory markers in patients with acute exacerbation of COPD Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008 Neutrophil CD 64 expression as a diagnostic marker of pneumonia in patients with acute COPD exacerbation Source: International Congress 2014 – Markers Year: 2014 Biomarkers for the prognostic assessment and disease severity evaluation in community-acquired pneumonia (CAP) Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010